Variceal bleeding and portal hypertension: new lights on old horizon.
New clinical, endoscopic, and imaging modalities for diagnosing varices and predicting bleeding are being investigated. Transnasal endoscopy and ultrathin battery-powered esophagoscopes are being used to improve patient comfort and compliance. Patients who respond to portal pressure-reducing drugs not only have a reduced risk of bleeding, but also a reduced risk of developing other complications, with improved survival. Nitrates have been shown to have no definite role in primary prophylaxis against variceal bleeding. The hemodynamic response to treatment has an independent prognostic value for the risk of variceal bleeding. Newer drugs have been investigated for reducing the hepatic venous pressure gradient, but with little success. Survival after bleeding has increased due to improved patient care and technological advances. Combined radiographic and endoscopic management of gastric varices is evolving and appears to be promising. Nonvariceal bleeding from portal hypertensive gastropathy is increasingly being recognized as a potential cause of bleeding in patients with portal hypertension, and pharmacotherapy with octreotide appears to be promising for the treatment of this condition. Variceal band ligation in children has been found to be as safe and effective as in adults.
Bhasin
D K
DK
Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. dkbhasin@sancharnet.in
Siyad
I
I
D003362:Cost-Benefit Analysis; D004932:Esophageal and Gastric Varices / Q000175:diagnosis* / Q000209:etiology / Q000401:mortality / Q000628:therapy; D006471:Gastrointestinal Hemorrhage / Q000175:diagnosis* / Q000209:etiology / Q000401:mortality / Q000628:therapy; D016558:Hemostasis, Endoscopic / Q000379:methods*; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications / Q000175:diagnosis*; D007422:Intestines / Q000473:pathology; D012307:Risk Factors; D015911:Sclerotherapy